Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Cancer Pathogenesis and Therapy
|
October 7, 2024
Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study
Peixian Chen, Yue Wang, Zhi Xiong, et al.
International Journal of Biological Sciences
|
September 23, 2024
Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer
Bingheng Li, Bisheng Cheng, Hao Huang, et al.
Frontiers in Bioengineering and Biotechnology
|
August 28, 2020
Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer
Ze Gao, Yiran Tao, Yiming Lai, et al.
Environmental Toxicology
|
November 16, 2023
MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer
Bisheng Cheng, Yiming Lai, Hao Huang, et al.
International Journal of Surgery (London, England)
|
July 15, 2024
Evaluating the effectiveness of cytoreductive surgery in oligometastatic prostate cancer: insights from quantitative analysis and retrospective cohort studies
Bisheng Cheng, Bingheng Li, Jianhan Fu, et al.
Advanced Healthcare Materials
|
May 27, 2025
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug Carrier
Bingliang Chen, Liying Wang, Ruihui Xie, et al.
Journal of Translational Medicine
|
April 27, 2025
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer
Ruilin Zhuang, Ruihui Xie, Shirong Peng, et al.
Biomaterials Science
|
January 3, 2024
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression
Zhi Xiong, Tong Tong, Zhaoxiang Xie, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 28, 2026
Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
Shirong Peng, Weilong Lin, Zean Li, et al.
Cancer Biology & Medicine
|
September 30, 2021
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
Qiong Wang, Zean Li, Jin Yang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Cancer Pathogenesis and Therapy
|
October 7, 2024
Association between autoimmunity-related disorders and prostate cancer: A Mendelian randomization study
Peixian Chen, Yue Wang, Zhi Xiong, et al.
International Journal of Biological Sciences
|
September 23, 2024
Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer
Bingheng Li, Bisheng Cheng, Hao Huang, et al.
Frontiers in Bioengineering and Biotechnology
|
August 28, 2020
Immune Cytolytic Activity as an Indicator of Immune Checkpoint Inhibitors Treatment for Prostate Cancer
Ze Gao, Yiran Tao, Yiming Lai, et al.
Environmental Toxicology
|
November 16, 2023
MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer
Bisheng Cheng, Yiming Lai, Hao Huang, et al.
International Journal of Surgery (London, England)
|
July 15, 2024
Evaluating the effectiveness of cytoreductive surgery in oligometastatic prostate cancer: insights from quantitative analysis and retrospective cohort studies
Bisheng Cheng, Bingheng Li, Jianhan Fu, et al.
Advanced Healthcare Materials
|
May 27, 2025
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug Carrier
Bingliang Chen, Liying Wang, Ruihui Xie, et al.
Journal of Translational Medicine
|
April 27, 2025
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer
Ruilin Zhuang, Ruihui Xie, Shirong Peng, et al.
Biomaterials Science
|
January 3, 2024
Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression
Zhi Xiong, Tong Tong, Zhaoxiang Xie, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
January 28, 2026
Cancer Cell-Intrinsic Cholesterol Induces Lipid-Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
Shirong Peng, Weilong Lin, Zean Li, et al.
Cancer Biology & Medicine
|
September 30, 2021
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
Qiong Wang, Zean Li, Jin Yang, et al.
Page
of 3